	Use of Vaginal Estrogen in Breast and Gynecologic Cancer Survivors. JCO Oncol Pract Burns JB, AlHilli MM, Ali A, Roesch E, Das D. PMID: 42832731 [PubMed - as supplied by publisher]
	The Impacts of Social Marketing Campaigns on Breast Cancer Awareness and Screening: Scoping Review. JMIR Cancer Abduljawad S. PMID: 42832730 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of self-sampling strategies for cervical cancer screening: a commentary. Br J Community Nurs Lewis G, Rabie T, Montes MA, Clegg A, Benedetto V. PMID: 42832409 [PubMed - indexed for MEDLINE]
	Impact of breast cancer on body image: a systematic review and meta-analysis. Arch Womens Ment Health Yazici Sarikaya S, Wang R, Kimmig AS, Bruecker S, Hahn M, Wikman A, Derntl B. PMID: 42832081 [PubMed - indexed for MEDLINE]
	Exosome-mediated organotropism in breast cancer metastasis: bridging the gap between molecular mechanisms and clinical application. Clin Exp Metastasis Pegushin DA, Oganesyan MV, Nikolenko VN. PMID: 42832062 [PubMed - indexed for MEDLINE]
	Preoperative CA15-3 as a predictor of axillary lymph node metastasis and prognosis in women with breast cancer: a GRADE-assessed systematic review and meta-analysis. Breast Cancer Bahardoust M, Rezaei A, Hosseinali A, Ranjbarpazuki G, Salehi S, Haghmoradi M, Rahmati S, Nafissi N. PMID: 42831963 [PubMed - as supplied by publisher]
	Falling Through the Cracks: Understanding Delayed Breast Cancer Diagnosis. J Gen Intern Med Smith R, Zipursky J, Donovan E. PMID: 42831956 [PubMed - as supplied by publisher]
	[Therapeutic success of sacituzumab govitecan in a patient with a primary diagnosis of triple-cancer: locally advanced triple-negative breast cancer, colon cancer and lung cancer.]. Recenti Prog Med Pernice G, Spada M. PMID: 42831722 [PubMed - indexed for MEDLINE]
	From Clinical Reality to Blueprint Designing: A Qualitative Study Exploring Communication Challenges and Unmet Needs for Patient Decision Aid Development in Early-Stage Breast Cancer. Psychooncology Sdinami S, Maialetti M, Sebri V, Zagami P, Grasso R, Curigliano G, Pravettoni G. PMID: 42831611 [PubMed - indexed for MEDLINE]
	Histopathological and Bioinformatic Analysis of the IL-6/STAT3 Signaling Pathway in Ovarian Neoplasms. Pak J Biol Sci Anika UL, Hellyanti T, Mahendra FR, Kodariah R. PMID: 42831402 [PubMed - indexed for MEDLINE]
	Redefining breast cancer treatment by precision oncology: the clinical impact of sacituzumab govitecan. Expert Opin Biol Ther Di Lauro V, Sacco PC, Palma V, von Arx C, Buono G, Caputo R, Piezzo M, Cocco S, Vitale E, Santoni M, Gridelli C, De Laurentiis M, Massafra R, Ciccimarra F, Rizzo A. PMID: 42831394 [PubMed - as supplied by publisher]
	Gedatolisib for the treatment of hormone receptor-positive/HER2-negative advanced breast cancer: a European perspective. Future Oncol Matera L, Etessami JD, Valenza C, Curigliano G. PMID: 42831391 [PubMed - as supplied by publisher]
	Advances in 3D Bioprinting for Breast Cancer Modeling: Tumor Microenvironment, Metastasis, and Drug Screening. Adv Healthc Mater Nakipoglu M, Mahmoodi M, Apu EH, Shahabipour F, Emir Diltemiz S, Saha S, Alem H, Ashammakhi N. PMID: 42831290 [PubMed - as supplied by publisher]
	Multi-omics studies identified the molecular network of mitochondrial dysfunction in the pathogenesis of breast cancer. Genes Dis Liu J, Guan X, Quan L, Dou M, Yuan P. PMID: 42831172 [PubMed]
	The influence of virtual reality on anxiety and pain in breast cancer patients: A systematic review. Tech Innov Patient Support Radiat Oncol Kundarti FI, Triwiyanto T, Titisari I, Sujianto U, Nurlaili A, Azmi ZF. PMID: 42831052 [PubMed]
	Chest wall pain as a late effect following radiotherapy for breast cancer: A systematic review of prevalence and risk factors. Tech Innov Patient Support Radiat Oncol Durrant L, Harris R, Atkinson C, Faithfull S. PMID: 42830996 [PubMed]
	VEGF-Leptin Crosstalk in Breast and Ovarian Cancer: Drivers of Angiogenesis and Progression. Cancer Manag Res Al-Eidan AA. PMID: 42830884 [PubMed]
	Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study. ESMO Real World Data Digit Oncol Fagotti A, Frenel JS, Saint-Ghislain M, Lim JT, Calderón Boyle TA, Golembesky AK, Hogg C, Arnold K, Braicu EI. PMID: 42830865 [PubMed]
	Integrative Multiomics Profiling Reveals Immune Determinants of Response to Disitamab Vedotin Plus Penpulimab in HER2-Low Breast Cancer. MedComm (2020) Liu X, Song Y, Liu L, Zhang AQ, Xie X, Wei B, He P, Zhuang C, Li J, Yan X, Tian T, Zhong X, Chen J, Cheng Y, Zheng D, Li S, Wang H, Luo T. PMID: 42830862 [PubMed]
	HER2-Targeted Antibody-Drug Conjugates in Advanced HER2-Low Breast Cancer: Mechanisms, Clinical Efficacy, and Resistance Strategies. Cancer Manag Res Yang M, Ding X, Ye P, Xu X. PMID: 42830854 [PubMed]

Articles 1 - 20 / 336073

Page 1 of 16804



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy